First Bioresorbable Vascular Scaffold Implantation in Patients with Acute Coronary Syndrome in the Republic of Macedonia

1. Maseri A. Ischemic Heart Disease, New York, Churchill Livingstone. 1995; 713.Search in Google Scholar

2. World Health Organization; Atlas of Heart Disease and Stroke. Deaths from Coronary Heart Disease. [2011].Search in Google Scholar

3. Strong K, et al. Preventing chronic diseases: how many lives can we save? Lancet. 2005; 366(9496): p. 1578-82.Search in Google Scholar

4. Gaziano TA, et al., Growing epidemic of coronary heart disease in low and middle-income countries. Curr Probl Cardiol. 2010; 35(2): p. 72-115.10.1016/j.cpcardiol.2009.10.002Search in Google Scholar

5. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992; 326: 242.10.1056/NEJM199201233260406Search in Google Scholar

6. Ross R, Fuster V. The patogenesis of atherosclerosis. In Fuster V, Ross R, Topol EJ (eds). Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott- Raven. 1996; 441-462.Search in Google Scholar

7. De Vreede JJM, Gorgels APM, Verstraaten GMP, et al. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol. 1991; 18: 698.10.1016/0735-1097(91)90792-8Search in Google Scholar

8. Rentrop KP. Restoration of anterograde flow in acute myocardial infarction: The first 15 years. J Am Coll Cardiol. 1995; 25: 1S.10.1016/0735-1097(95)00143-RSearch in Google Scholar

9. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003; 361(9351): 13-20.10.1016/S0140-6736(03)12113-7Search in Google Scholar

10. Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011; 32(15): 1854-1864 (Epub 2011 Jun 29).Search in Google Scholar

11. Elbarouni B, Elmanfuld O, Yan RT, et al. Temporal trend of in-hospital major bleeding among patients with non ST-elevation acute coronary syndromes. Am Heart J. 2010; 160(3): 420-427.10.1016/j.ahj.2010.05.03620826248Search in Google Scholar

12. Stone GW, Maehara A, Lansky AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364: 226-235.10.1056/NEJMoa100235821247313Search in Google Scholar

13. Yeh RW, Sidney S, Chandra M, et al. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362: 2155-2165.10.1056/NEJMoa090861020558366Search in Google Scholar

14. Fox KA, Eagle KA, Gore JM, et al. The Global Registry of Acute Coronary Events, 1999 to 2009 - GRACE. Heart. 2010; 96: 1095-1101.10.1136/hrt.2009.19082720511625Search in Google Scholar

15. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA. 1999; 281: 707-713.10.1001/jama.281.8.70710052440Search in Google Scholar

16. Mandelzweig L, Battler A, Boyko V, et al. The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004. Eur Heart J. 2006; 27: 2285-2293.10.1093/eurheartj/ehl196Search in Google Scholar

17. Dubois C, Pierard LA, Smeets JP, et al. Short and long term prognostic importance of complete bundle branch complicating acute myocardial infarction. Clin Cardiol. 1988; 11: 292.10.1002/clc.4960110504Search in Google Scholar

18. Bjerregaard P, Gussak I, Kotar SL, et al. Recurrent syncope in a patient with prominent J wave. Am Heart J. 1994; 127: 1426.10.1016/0002-8703(94)90070-1Search in Google Scholar

19. Braunwald E. The open-artery theory is alive and well - again. N Engl J Med. 1993; 329: 1650.10.1056/NEJM199311253292211Search in Google Scholar

20. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. Am Coll Cardiol. 1992; 20: 1391.10.1016/0735-1097(92)90253-JSearch in Google Scholar

21. Cannon A, Freedman SB, Bailey BP, et al. ST-segment changes during transmural myocardial ischemia in chronic left bundle branch block. Am J Cardiol. 1989; 64: 1216.10.1016/0002-9149(89)90886-2Search in Google Scholar

22. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndrome. Am J Cardiol. 1989; 63: 114E.10.1016/0002-9149(89)90242-7Search in Google Scholar

23. Fallon JT. Pathology of myocardial infarction and reperfusion. In Fuster V, Ross R, and Topol EJ (eds). Atherosclerosis and Coronary Artery Disease. Philadelphia, Lippincott-Raven. 1996; 791-796.Search in Google Scholar

24. Fesmire FM. ECG diagnosis of acute myocardial infarction in the presence of left bundle-branch block in patients undergoing continuous ECG monitoring. Ann Emerg Med. 1995; 26: 69-82.10.1016/S0196-0644(95)70241-5Search in Google Scholar

25. Flowers NC. Left bundle branch block: A continuously evolving concept. J Am Coll Cardiol. 1987; 9: 684.10.1016/S0735-1097(87)80065-7Search in Google Scholar

26. Forrester JS, Wyatt HL, Daluz, PL, et al. Functional significance of regional ischaemic contraction abnormalities. Circulation. 1976; 54: 64.10.1161/01.CIR.54.1.64Search in Google Scholar

27. Hands ME, Cook EF, Stone PH, et al. Electrocardiographic diagnosis of myocardial infarction in the presence of complete bundle branch block. Am Heart J. 1988; 116: 23.10.1016/0002-8703(88)90245-1Search in Google Scholar

28. Lamas GA, Mueller JE, Turi AG, et al. A simplified method to predict occurence of complete heart block during acute myocardial infarction. Am J Cardiol. 1986; 57: 1213.10.1016/0002-9149(86)90191-8Search in Google Scholar

29. Mullins CB, Atkins JM. Prognoses and management of ventricular conduction blocks in acute myocardial infarction. Mod Concepts Cardiovasc Dis. 1976; 45: 129.Search in Google Scholar

30. Oreto G, Saporito F, Donato G, et al. The "Inverse" R wave progression in inferior leads in the presence of left anterior hemiblock: A clinical study. J Electrocardiol. 1991; 24: 277.10.1016/0022-0736(91)90034-JSearch in Google Scholar

31. Ricou F, Nicod P, Gilpin E, et al. Influence of right bundle branch block on short and long term survival after acute anterior myocardial infarction. J Am Coll Cardiol. 1991; 17: 858.10.1016/0735-1097(91)90865-7Search in Google Scholar

32. Rosenbaum MB, Girotti LA, Lazzari JO, et al. Abnormal Q waves in right sided chest leads provoked by onset of right bundle branch block in patients with antero-septal infarction. Br Heart J. 1982; 47: 227.10.1136/hrt.47.3.227Search in Google Scholar

33. Scheinman MM, Gonzales RP. Fascicular block and acute myocardial infarction. JAMA. 1980; 244: 2646.10.1001/jama.1980.03310230046027Search in Google Scholar

34. Schuster EH, Bulkley BH. Ischemia at a distance after acute myocardial infarction: A cause of early postinfarction angina. Circulation. 1980; 62: 509.10.1161/01.CIR.62.3.509Search in Google Scholar

35. Watt TBJr, Freud GE, Durrer D, et al. Left anterior arborization block combined with right bundle branch block in canine and primate hearts. An electrocardiographic study. Circ Res. 1968; 22: 57.10.1161/01.RES.22.1.57Search in Google Scholar

36. White HD, Norris RM, Brown MA, et al. Left ventricular end sistolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987; 76: 44.10.1161/01.CIR.76.1.44Search in Google Scholar

37. Willems JL, Robles de Medina E, Bernard R, et al. WHO task force on criteria for intraventricular conduction disturbances and pre-excitation. J Am Coll Cardiol. 1985; 5: 1261.10.1016/S0735-1097(85)80335-1Search in Google Scholar

38. Brilakis E, Wright S, Kopecky S, et al. Bundle branch block as a predictor of long-term survival after acute myocardial infarction. Am J Cardiol. 2001; 88: 205-209.10.1016/S0002-9149(01)01626-5Search in Google Scholar

39. Go AS, Barron HV, Rundle AC, et al. Bundle branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med. 1998; 129: 690-697.Search in Google Scholar

40. Serruys P. and Y. Onuma, 5-Year Cohort A and 2- Year Cohort B Results: Integrated Insights, in TCT 2011: San Francisco.Search in Google Scholar

41. Chevalier B. ABSORB Cohort B Trial: Evaluation of the ABSORB Bioresorbable Everolimus-Eluting Vascular Scaffold in the Treatment of Patients with de novo Native Coronary Artery Lesions. in American College of Cardiology. 2011. New Orleans.10.1016/S0735-1097(11)61642-2Search in Google Scholar

42. Dudek D. ABSORB Cohort B Trial: Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de novo Native Coronary Artery Lesions - 2-Year Clinical Results in American College of Cardiology. 2012. Chicago.10.1016/S0735-1097(12)60320-9Search in Google Scholar

43. Van Geuns, R.J. Preliminary data from ABSORB EXTEND: A report of the 6-month clinical outcomes from the first 269 patients registered, in EuroPCR Focus on BVS 2012, (presentation): Rotterdam, Netherlands.Search in Google Scholar

44. Onuma, Y. and P. Serruys. Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? Circulation. 2011; 123: p. 779-797.10.1161/CIRCULATIONAHA.110.971606Search in Google Scholar

45. Koster R et al. Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis. Lancet, 2000. 356(9245): p. 1895-7.10.1016/S0140-6736(00)03262-1Search in Google Scholar

46. Diletti R, Farooq V, Girasis C, et al. Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart. 2013; 99: 98-105.10.1136/heartjnl-2012-30259823118346Search in Google Scholar

47. Muramatsu T, Onuma Y, Garcia-Garcia HM, et al. Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORBEXTEND single-arm trial in comparison with an everolimus- eluting metallic stent in the SPIRIT first and II trials. JACC Cardiovasc Interv. 2013; 6: 247-257.10.1016/j.jcin.2012.10.01323517836Search in Google Scholar

48. Iqbal J, Onuma Y, Ormiston J et al. Bioresorbable coronary scaffolds: a novel device-based solution in search of its clinical need. Eur Heart J. 2014; 35: 753-757.10.1093/eurheartj/ehu00524553720Search in Google Scholar

49. Serruys PW, Onuma Y, Garcia-Garcia HM et al. Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention 2014; in press.10.4244/EIJV9I11A21724291783Search in Google Scholar

50. Dilleti R, Serruys PW, Farooq V, et al. ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, afficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-elu ting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design. Am Heart J. 2012; 164: 654-63.10.1016/j.ahj.2012.08.01023137495Search in Google Scholar